TY - JOUR AU - Verspoor, F. G. AU - Zee, A. A. AU - Hannink, G. PY - 2014 DA - 2014// TI - Long-term follow-up results of primary and recurrent pigmented villonodular synovitis JO - Rheumatology VL - 53 UR - https://doi.org/10.1093/rheumatology/keu230 DO - 10.1093/rheumatology/keu230 ID - Verspoor2014 ER - TY - JOUR AU - Brahmi, M. AU - Vinceneux, A. AU - Cassier, P. A. PY - 2016 DA - 2016// TI - Current systemic treatment options for tenosynovial giant cell tumor/pigmented villodular synovitis: Targeting CSF1/CSF1R Axis JO - Curr Treat Options in Oncol VL - 17 UR - https://doi.org/10.1007/s11864-015-0385-x DO - 10.1007/s11864-015-0385-x ID - Brahmi2016 ER - TY - JOUR AU - Ravi, V. AU - Wang, W. L. AU - Lewis, V. O. PY - 2011 DA - 2011// TI - Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis JO - Curr Opin Oncol VL - 23 UR - https://doi.org/10.1097/CCO.0b013e328347e1e3 DO - 10.1097/CCO.0b013e328347e1e3 ID - Ravi2011 ER - TY - JOUR AU - Molena, B. AU - Sfriso, P. AU - Oliviero, F. PY - 2011 DA - 2011// TI - Synovial colony-stimulating factor-1 mRNA expression in diffuse pigmented villonodular synovitis JO - Clin Exp Rheumatol VL - 29 ID - Molena2011 ER - TY - JOUR AU - West, R. B. AU - Rubin, B. P. AU - Miller, M. A. PY - 2006 DA - 2006// TI - A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells JO - Proc Natl Acad Sci U S A VL - 103 UR - https://doi.org/10.1073/pnas.0507321103 DO - 10.1073/pnas.0507321103 ID - West2006 ER - TY - JOUR AU - Cupp, J. S. AU - Miller, M. A. AU - Montgomery, K. D. PY - 2007 DA - 2007// TI - Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides JO - Am J Surg Pathol VL - 31 UR - https://doi.org/10.1097/PAS.0b013e31802b86f8 DO - 10.1097/PAS.0b013e31802b86f8 ID - Cupp2007 ER - TY - JOUR AU - Tap, W. D. AU - Wainberg, Z. A. AU - Anthony, S. P. PY - 2015 DA - 2015// TI - Structure-guided blockade of CSF1R kinase in Tenosynovial Giant-cell tumor JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1411366 DO - 10.1056/NEJMoa1411366 ID - Tap2015 ER - TY - JOUR AU - Eckhardt, S. G. AU - Porre, P. AU - Smith, D. PY - 2009 DA - 2009// TI - Patient-reported outcomes as a component of the primary endpoint in a double-blind, placebo-controlled trial in advanced pancreatic cancer JO - J Pain Symptom Manag VL - 37 UR - https://doi.org/10.1016/j.jpainsymman.2008.02.007 DO - 10.1016/j.jpainsymman.2008.02.007 ID - Eckhardt2009 ER - TY - STD TI - Food and Drug Administration. Clinical Trial Endpoints for the Approval of Non-Small Cell Lung Cancer Drugs and Biologics Guidance for Industry 2015 [February 14, 2017]. Available from: http://www.fda.gov/downloads/Drugs/Guidances/UCM259421.pdf UR - http://www.fda.gov/downloads/Drugs/Guidances/UCM259421.pdf ID - ref9 ER - TY - JOUR AU - Thomas, D. M. PY - 2015 DA - 2015// TI - The growing problem of benign connective tissue tumours JO - The Lancet Oncology VL - 16 UR - https://doi.org/10.1016/S1470-2045(15)00147-3 DO - 10.1016/S1470-2045(15)00147-3 ID - Thomas2015 ER - TY - JOUR AU - Gelhorn, H. L. AU - Tong, S. AU - McQuarrie, K. PY - 2016 DA - 2016// TI - Patient-reported symptoms of Tenosynovial Giant cell tumors JO - Clin Ther VL - 38 UR - https://doi.org/10.1016/j.clinthera.2016.03.008 DO - 10.1016/j.clinthera.2016.03.008 ID - Gelhorn2016 ER - TY - JOUR AU - Cella, D. AU - Yount, S. AU - Rothrock, N. PY - 2007 DA - 2007// TI - The patient-reported outcomes measurement information system (PROMIS): Progress of an NIH roadmap cooperative group during its first two years JO - Med Care VL - 45 UR - https://doi.org/10.1097/01.mlr.0000258615.42478.55 DO - 10.1097/01.mlr.0000258615.42478.55 ID - Cella2007 ER - TY - JOUR AU - DeWalt, D. A. AU - Rothrock, N. AU - Yount, S. PY - 2007 DA - 2007// TI - Evaluation of item candidates: The PROMIS qualitative item review JO - Med Care VL - 45 UR - https://doi.org/10.1097/01.mlr.0000254567.79743.e2 DO - 10.1097/01.mlr.0000254567.79743.e2 ID - DeWalt2007 ER - TY - JOUR AU - Rose, M. AU - Bjorner, J. B. AU - Becker, J. PY - 2008 DA - 2008// TI - Evaluation of a preliminary physical function item bank supported the expected advantages of the patient-reported outcomes measurement information system (PROMIS) JO - J Clin Epidemiol VL - 61 UR - https://doi.org/10.1016/j.jclinepi.2006.06.025 DO - 10.1016/j.jclinepi.2006.06.025 ID - Rose2008 ER - TY - JOUR AU - Bruce, B. AU - Fries, J. F. AU - Ambrosini, D. PY - 2009 DA - 2009// TI - Better assessment of physical function: Item improvement is neglected but essential JO - Arthritis research & therapy VL - 11 UR - https://doi.org/10.1186/ar2890 DO - 10.1186/ar2890 ID - Bruce2009 ER - TY - JOUR AU - Hung, M. AU - Clegg, D. O. AU - Greene, T. PY - 2012 DA - 2012// TI - A lower extremity physical function computerized adaptive testing instrument for orthopaedic patients JO - Foot & ankle international VL - 33 UR - https://doi.org/10.3113/FAI.2012.0326 DO - 10.3113/FAI.2012.0326 ID - Hung2012 ER - TY - JOUR AU - Hung, M. AU - Baumhauer, J. F. AU - Latt, L. D. PY - 2013 DA - 2013// TI - Validation of PROMIS (R) Physical Function computerized adaptive tests for orthopaedic foot and ankle outcome research JO - Clin Orthop Relat Res VL - 471 UR - https://doi.org/10.1007/s11999-013-3097-1 DO - 10.1007/s11999-013-3097-1 ID - Hung2013 ER - TY - JOUR AU - Oude Voshaar, M. A. AU - Klooster, P. M. AU - Glas, C. A. PY - 2015 DA - 2015// TI - Validity and measurement precision of the PROMIS physical function item bank and a content validity-driven 20-item short form in rheumatoid arthritis compared with traditional measures JO - Rheumatology VL - 54 UR - https://doi.org/10.1093/rheumatology/kev265 DO - 10.1093/rheumatology/kev265 ID - Oude Voshaar2015 ER - TY - JOUR AU - Hays, R. D. AU - Spritzer, K. L. AU - Fries, J. F. PY - 2015 DA - 2015// TI - Responsiveness and minimally important difference for the patient-reported outcomes measurement information system (PROMIS) 20-item physical functioning short form in a prospective observational study of rheumatoid arthritis JO - Ann Rheum Dis VL - 74 UR - https://doi.org/10.1136/annrheumdis-2013-204053 DO - 10.1136/annrheumdis-2013-204053 ID - Hays2015 ER - TY - STD TI - PROMIS. Physical Function, a brief guide to the PROMIS Physical Function instruments September 9, 2015 [March 9, 2017]. Available from: https://www.assessmentcenter.net/documents/PROMIS%20Physical%20Function%20Scoring%20Manual.pdf UR - https://www.assessmentcenter.net/documents/PROMIS%20Physical%20Function%20Scoring%20Manual.pdf ID - ref20 ER - TY - JOUR AU - Magasi, S. AU - Ryan, G. AU - Revicki, D. PY - 2012 DA - 2012// TI - Content validity of patient-reported outcome measures: Perspectives from a PROMIS meeting JO - Qual Life Res VL - 21 UR - https://doi.org/10.1007/s11136-011-9990-8 DO - 10.1007/s11136-011-9990-8 ID - Magasi2012 ER - TY - JOUR AU - Garcia, S. F. AU - Cella, D. AU - Clauser, S. B. PY - 2007 DA - 2007// TI - Standardizing patient-reported outcomes assessment in cancer clinical trials: A patient-reported outcomes measurement information system initiative JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2007.12.2341 DO - 10.1200/JCO.2007.12.2341 ID - Garcia2007 ER - TY - STD TI - Garcia SF, George J, Rosenbloom SK, et al. Adapting chronic illness health related quality of life item banks for cancer populations. Budapest: Poster presented at the International Society for Quality of Life Research Conference on Patient-Reported Outcomes in Clinical Practice; 2007. ID - ref23 ER - TY - JOUR AU - Wynder, E. L. PY - 1994 DA - 1994// TI - Investigator bias and interviewer bias: The problem of reporting systematic error in epidemiology JO - J Clin Epidemiol VL - 47 UR - https://doi.org/10.1016/0895-4356(94)90184-8 DO - 10.1016/0895-4356(94)90184-8 ID - Wynder1994 ER - TY - STD TI - European Medicines Agency. Reflection Paper on the Regulatory Guidance for the use of Health Related Quality of Life (HRQL) Measure in the Evaluation of Medicinal Products 2005 [March 9, 2017]. Available from: https://www.ema.europa.eu/documents/scientific-guideline/reflection-paper-regulatory-guidance-use-healthrelated-quality-life-hrql-measures-evaluation_en.pdf. UR - https://www.ema.europa.eu/documents/scientific-guideline/reflection-paper-regulatory-guidance-use-healthrelated-quality-life-hrql-measures-evaluation_en.pdf ID - ref25 ER - TY - JOUR PY - 2009 DA - 2009// TI - Guidance for industry on patient-reported outcome measures: Use in medical product development to support labeling claims JO - Fed Regist VL - 74 ID - ref26 ER - TY - JOUR AU - Chung, H. AU - Kim, J. AU - Cook, K. F. PY - 2014 DA - 2014// TI - Testing measurement invariance of the patient-reported outcomes measurement information system pain behaviors score between the US general population sample and a sample of individuals with chronic pain JO - Qual Life Res VL - 23 UR - https://doi.org/10.1007/s11136-013-0463-0 DO - 10.1007/s11136-013-0463-0 ID - Chung2014 ER - TY - JOUR AU - Cook, K. F. AU - Bamer, A. M. AU - Amtmann, D. PY - 2012 DA - 2012// TI - Six patient-reported outcome measurement information system short form measures have negligible age- or diagnosis-related differential item functioning in individuals with disabilities JO - Arch Phys Med Rehabil VL - 93 UR - https://doi.org/10.1016/j.apmr.2011.11.022 DO - 10.1016/j.apmr.2011.11.022 ID - Cook2012 ER -